INSYS Therapeutics Announces Closing of IPO and Exercise of Underwriters' Over-Allotment Option
5/7/2013 10:38:22 AM
More...
|
INSYS Therapeutics Announces Pricing of IPO
5/2/2013 7:26:07 AM
More...
|
INSYS Therapeutics Announces the Availability of SUBSYS(TM) (Fentanyl Sublingual Spray) for Breakthrough Cancer Pain
3/26/2012 9:13:31 AM
More...
|
INSYS Therapeutics Announces FDA Approval of SUBSYS(R) Fentanyl Sublingual Spray
1/5/2012 6:59:31 AM
More...
|
INSYS Therapeutics Announces Addition of VP of Marketing to Commercial Team
12/5/2011 9:20:24 AM
More...
|
INSYS Therapeutics Announces Commercial Team Additions
11/2/2011 8:44:06 AM
More...
|
INSYS Therapeutics Announces NDA PDUFA Date for Fentanyl SL Spray
5/23/2011 7:25:10 AM
More...
|
INSYS Therapeutics Announces NDA PDUFA Date for Fentanyl SL Spray
5/20/2011 10:50:10 AM
More...
|
INSYS Therapeutics Announces NDA Acceptance of its Fentanyl SL Spray
5/12/2011 10:34:54 AM
More...
|
INSYS Therapeutics Announces Submission of NDA for Fentanyl SL Spray
3/7/2011 5:24:57 PM
More...
|
|